Correlation Between GlobalData PLC and Viridian Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlobalData PLC and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlobalData PLC and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlobalData PLC and Viridian Therapeutics, you can compare the effects of market volatilities on GlobalData PLC and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlobalData PLC with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlobalData PLC and Viridian Therapeutics.

Diversification Opportunities for GlobalData PLC and Viridian Therapeutics

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between GlobalData and Viridian is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding GlobalData PLC and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and GlobalData PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlobalData PLC are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of GlobalData PLC i.e., GlobalData PLC and Viridian Therapeutics go up and down completely randomly.

Pair Corralation between GlobalData PLC and Viridian Therapeutics

Assuming the 90 days trading horizon GlobalData PLC is expected to generate 0.46 times more return on investment than Viridian Therapeutics. However, GlobalData PLC is 2.19 times less risky than Viridian Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  15,495  in GlobalData PLC on October 23, 2024 and sell it today you would earn a total of  2,855  from holding GlobalData PLC or generate 18.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy94.97%
ValuesDaily Returns

GlobalData PLC  vs.  Viridian Therapeutics

 Performance 
       Timeline  
GlobalData PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlobalData PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, GlobalData PLC is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Viridian Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

GlobalData PLC and Viridian Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlobalData PLC and Viridian Therapeutics

The main advantage of trading using opposite GlobalData PLC and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlobalData PLC position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.
The idea behind GlobalData PLC and Viridian Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
CEOs Directory
Screen CEOs from public companies around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Directory
Find actively traded commodities issued by global exchanges